EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Robotic Partial Cystectomy and Extended Pelvic Lymph Node Dissection for Node-Positive Urachal Adenocarcinoma in a 34-Year-Old Woman: A Case Report

Stefanie Herrmann, Christian Gilfrich iD, Stephan Siepmann, Julio Ruben Rodas Garzaro iD, Fabian Eder, Stephan Schleder iD, Philipp Aubele, Felix Keil iD, Matthias May, Anton Kravchuk iD

Current Oncology · 30.03.2026 · 33 (4) · 190

DOI: 10.3390/curroncol33040190 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Current Oncology, online erschienen am 30.03.2026. Verfasst von Stefanie Herrmann und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Merciful Brothers Hospital St. Elisabeth, 94315 Straubing, Germany. Hauptthemen laut MEDLINE: Lymph Node Excision, Cystectomy, Adenocarcinoma, Urinary Bladder Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Urachal carcinoma is a rare and aggressive malignancy for which standardized management remains limited, particularly in patients with locally advanced and node-positive disease. We report the case of a 34-year-old woman with urachal adenocarcinoma involving the bladder dome and radiographically suspicious pelvic lymph nodes who underwent robot-assisted partial cystectomy with urachal resection and extended bilateral pelvic lymph node dissection. Because there was no clinical, radiologic, or intraoperative evidence of umbilical involvement, the umbilicus was preserved after preoperative counseling and intraoperative confirmation of a negative proximal margin. Final pathology demonstrated a 4.5 cm enteric-type urachal adenocarcinoma, pT3a pN2 (2/17), with lymphovascular invasion, perineural invasion, and negative surgical margins. Immunohistochemistry and DNA- and RNA-based next-generation sequencing showed microsatellite stability, mismatch-repair proficiency, low tumor mutational burden, and no actionable genomic alteration. Given the absence of an established adjuvant standard, the multidisciplinary tumor board selected adjuvant FOLFOX as a non-standard postoperative strategy based on the overall clinicopathologic context. The patient remained continent, experienced no postoperative complications or treatment-limiting toxicity, and showed normalization of carcinoembryonic antigen and carbohydrate antigen 19-9 levels. This case provides a carefully contextualized example of transparent surgical reasoning and restrained multidisciplinary management in a rare malignancy with limited prospective evidence.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lymph Node ExcisionCystectomyAdenocarcinomaUrinary Bladder NeoplasmsHumansFemaleAdultLymphatic MetastasisPelvisRobotic Surgical ProceduresImmunohistochemistryAntineoplastic Combined Chemotherapy ProtocolsLeucovorinFluorouracilOrganoplatinum Compounds

Stichwörter der Autor:innen

adjuvant chemotherapyminimally invasive surgerymolecular profilingmultidisciplinary tumor boardpelvic lymph node dissectionprecision oncologyrare genitourinary malignancyurachal adenocarcinoma

Substanzen

LeucovorinFluorouracilOrganoplatinum Compounds

Autor:innen und Institutionen

  • Department of Urology, Merciful Brothers Hospital St. Elisabeth, 94315 Straubing, Germany.
  • Institute of Pathology, Hospital Deggendorf, 94469 Deggendorf, Germany.
  • Department of Diagnostic and Interventional Radiology, Merciful Brothers Hospital St. Elisabeth, 94315 Straubing, Germany.
  • Department of Hematology and Oncology, Straubing Hospital Medical Care Center, 94315 Straubing, Germany.
  • Institute of Pathology, University of Regensburg, 93053 Regensburg, Germany.

ORCID-Profile: Christian Gilfrich, Julio Ruben Rodas Garzaro, Stephan Schleder, Felix Keil, Anton Kravchuk

Zitieren

APA

Herrmann, S., Gilfrich, C., Siepmann, S., Rodas Garzaro, J. R., Eder, F., Schleder, S., Aubele, P., Keil, F., May, M., & Kravchuk, A. (2026). Robotic Partial Cystectomy and Extended Pelvic Lymph Node Dissection for Node-Positive Urachal Adenocarcinoma in a 34-Year-Old Woman: A Case Report. Current Oncology, 33(4), 190. https://doi.org/10.3390/curroncol33040190

Vancouver

Herrmann S, Gilfrich C, Siepmann S, Rodas Garzaro JR, Eder F, Schleder S, et al. Robotic Partial Cystectomy and Extended Pelvic Lymph Node Dissection for Node-Positive Urachal Adenocarcinoma in a 34-Year-Old Woman: A Case Report. Current Oncology. 2026;33(4):190. doi:10.3390/curroncol33040190

BibTeX
@article{Herrmann2026,
  author = {Herrmann, Stefanie and Gilfrich, Christian and Siepmann, Stephan and Rodas Garzaro, Julio Ruben and Eder, Fabian and Schleder, Stephan and Aubele, Philipp and Keil, Felix and May, Matthias and Kravchuk, Anton},
  title = {Robotic Partial Cystectomy and Extended Pelvic Lymph Node Dissection for Node-Positive Urachal Adenocarcinoma in a 34-Year-Old Woman: A Case Report},
  journal = {Current Oncology},
  year = {2026},
  volume = {33},
  number = {4},
  pages = {190},
  doi = {10.3390/curroncol33040190}
}
Kostenlos starten →